Compare VECO & QURE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | VECO | QURE |
|---|---|---|
| Founded | 1945 | 1998 |
| Country | United States | Netherlands |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.9B | 1.9B |
| IPO Year | 1994 | 2007 |
| Metric | VECO | QURE |
|---|---|---|
| Price | $30.90 | $20.42 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 6 | 12 |
| Target Price | $28.00 | ★ $58.55 |
| AVG Volume (30 Days) | 632.4K | ★ 2.4M |
| Earning Date | 11-05-2025 | 11-10-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.83 | N/A |
| Revenue | ★ $681,408,000.00 | $15,751,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $9.81 | $158.05 |
| P/E Ratio | $36.86 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $16.92 | $7.76 |
| 52 Week High | $34.45 | $71.50 |
| Indicator | VECO | QURE |
|---|---|---|
| Relative Strength Index (RSI) | 54.95 | 28.70 |
| Support Level | $31.49 | $20.55 |
| Resistance Level | $33.41 | $28.50 |
| Average True Range (ATR) | 1.12 | 1.35 |
| MACD | 0.12 | 0.23 |
| Stochastic Oscillator | 53.69 | 12.27 |
Veeco Instruments Inc is a United States-based company engaged in designing, developing, and manufacturing thin-film process equipment, mainly used for producing electronic devices. The company focuses on semiconductor process equipment that addresses a range of challenging materials engineering problems for its customers. Its products include Laser Processing Systems, Lithography Systems, Ion Beam Systems, SiC CVD Systems, MOCVD Systems, Wet Processing Systems, MBE Technologies, Atomic Layer Deposition Systems, Physical Vapor Deposition Systems, Dicing and Lapping Systems, as well as Gas & Vapor Delivery Systems. The majority of the company's revenue is generated from sales to the Semiconductor Industry and within China.
uniQure NV is a gene therapy company. It develops treatments and platforms for patients suffering from genetic and other devastating diseases. Its products and services are focused on hemophilia, Huntington's disease, and cardiovascular diseases. The company is focused on the development of the pipeline of gene therapies with the collaboration of Bristol Myers Squibb for cardiovascular diseases.